Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07131813) titled 'Evaluation of Efficacy and Safety of add-on Tofacitinib in Patients With Oral Lichen Planus' on Aug. 13.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
Primary Sponsor: All India Institute of Medical Sciences, Bhubaneswar
Condition:
Oral Lichen Planus
Intervention:
Drug: Tofacitinib 5 mg BID and Triamcinolone ointment
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: September 1, 2025
Target Sample Size: 60
Countries of Recruitment:
India
To know...